Literature DB >> 25972405

Vaccination with the ospA- and ospB-Negative Borrelia burgdorferi Strain 50772 Provides Significant Protection against Canine Lyme Disease.

Rhonda L LaFleur1, Steven M Callister2, Jennifer C Dant1, Terri L Wasmoen1, Dean A Jobe3, Steven D Lovrich3.   

Abstract

Beagles received placebo or ospA- and ospB-negative Borrelia burgdorferi before a tick challenge. A total of 28 (41%) ticks and skin biopsy specimens from each control dog (n = 10) contained B. burgdorferi. In contrast, 12 (19%) ticks recovered from the vaccine recipients (n = 10) were infected (P = 0.0077), and 5 dogs yielded spirochetes from the skin biopsy specimens (P = 0.0325). In addition, 9 (90%) placebo recipients and 4 (40%) vaccine recipients developed joint abnormalities (P = 0.0573). Therefore, vaccination with the ospA- and ospB-negative spirochete provided significant protection against Lyme disease.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25972405      PMCID: PMC4478514          DOI: 10.1128/CVI.00193-15

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  24 in total

1.  Synovial lesions in experimental canine Lyme borreliosis.

Authors:  L Susta; E W Uhl; D A Grosenbaugh; P M Krimer
Journal:  Vet Pathol       Date:  2011-11-10       Impact factor: 2.221

2.  Borrelia burgdorferi ospC heterogeneity among human and murine isolates from a defined region of northern Maryland and southern Pennsylvania: lack of correlation with invasive and noninvasive genotypes.

Authors:  Muneera Y Alghaferi; Jennifer M Anderson; Jinho Park; Paul G Auwaerter; John N Aucott; Douglas E Norris; J Stephen Dumler
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 3.  Immunological and molecular variability of OspA and OspC. Implications for Borrelia vaccine development.

Authors:  B Wilske; U Busch; V Fingerle; S Jauris-Heipke; V Preac Mursic; D Rössler; G Will
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

4.  Histopathological studies of experimental lyme disease in the dog.

Authors:  B A Summers; A F Straubinger; R H Jacobson; Y-F Chang; M J G Appel; R K Straubinger
Journal:  J Comp Pathol       Date:  2005-07       Impact factor: 1.311

5.  Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.

Authors:  Steven D Lovrich; Dean A Jobe; Ronald F Schell; Steven M Callister
Journal:  Clin Diagn Lab Immunol       Date:  2005-06

6.  Morphologic, immunohistochemical, and ultrastructural characterization of a distinctive renal lesion in dogs putatively associated with Borrelia burgdorferi infection: 49 cases (1987-1992).

Authors:  D M Dambach; C A Smith; R M Lewis; T J Van Winkle
Journal:  Vet Pathol       Date:  1997-03       Impact factor: 2.221

7.  Presence and distribution of Borrelia burgdorferi sensu lato species in internal organs and skin of naturally infected symptomatic and asymptomatic dogs, as detected by polymerase chain reaction.

Authors:  K E Hovius; L A Stark; N M Bleumink-Pluym; I van de Pol; N Verbeek-de Kruif; S G Rijpkema; L M Schouls; D J Houwers
Journal:  Vet Q       Date:  1999-04       Impact factor: 3.320

8.  Astasia and pyrexia related to Borrelia garinii infection in two dogs in Hokkaido, Japan.

Authors:  Hisashi Inokuma; Shigeki Maetani; Jyunji Fujitsuka; Ai Takano; Kozue Sato; Takashi Fukui; Toshiyuki Masuzawa; Hiroki Kawabata
Journal:  J Vet Med Sci       Date:  2013-02-22       Impact factor: 1.267

9.  Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection.

Authors:  S D Lovrich; S M Callister; B K DuChateau; L C Lim; J Winfrey; S P Day; R F Schell
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

10.  Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.

Authors:  A M de Silva; S R Telford; L R Brunet; S W Barthold; E Fikrig
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  1 in total

1.  Efficacy of Borrelia burgdorferi vaccine in dogs in North America: A systematic review and meta-analysis.

Authors:  Nadine A Vogt; Jan M Sargeant; Melissa C MacKinnon; Ali M Versluis
Journal:  J Vet Intern Med       Date:  2018-12-03       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.